Bacterial resistance against antibiotics;Bakteriell resistens mot antibiotika

Tidsskrift for den Norske Laegeforening

Volumn 128, Issue 21, 2008, Pages 2452-2456

  Høiby, E Arne ^a   Vestrheim, Didrik F ^a   Caugant, Dominique A ^b,c   Gammelsrud, Karianne Wiger ^b,d  

^a Nasjonalt Folkehelseinstitutt   (Norway)

^b Universitetet I Oslo ^*

^c UNIVERSITY OF OSLO   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG UTILIZATION; GENETICS; HUMAN; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 56549103926     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Thomas L. The youngest science. Notes of a medicine-watcher. New York: Viking Press, 1983.
2. Tilghman RC, Finland M. Pneumococcal bacteremia. Arch Intern Med 1937; 59: 602-19.
3. McDermott W, Rogers DE. Social ramifications of control of infectious disease. Johns Hopkins Med J 1982; 151: 302-12.
4. Gorbach SL. Abdominal infections. Clin Infect Dis 1993; 17: 961-7.
5. Spellberg B, Guidos R, Gilbert D et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 155-64.
6. Baquero F, Nombela C, Cassell GH et al. Evolutionary biology of bacterial and fungal pathogens. Washington, D.C.: ASM Press, 2008.
7. Bryskier A, red. Antimicrobial agents. Antibacterials and antifungals. Washington, D.C.: ASM Press, 2005.
8. Opal SM, Medeiros AA. Molecular mechanisms of antibiotic resistance in bacteria. I: Mandrell GL, Bennett JL, Dolin R, red. Principles and practice of infectious diseases. 6. utg. Baltimore: Churchill Livingstone, 2005: 253-70.
9. AFA (Arbeidsgruppen for antibiotikaspørsmål). AFAS brytningspunkter for bakteriers antibiotikafølsomhet. Versjon 1.11, gjeldende fra 1.3.2008. Oslo: Arbeidsgruppen for antibiotikaspørsmå l, 2008.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. [M100-S16]. Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
11. Amsden GW. Tables of antimicrobial agent pharmacology. I: Mandrell GL, Bennett JL, Dolin R, red. Principles and practice of infectious diseases. 6. utg. Baltimore: Churchill Livingstone, 2005: 634-700.
12. Kahlmeter G. Hva er resistens og hvordan etableres brytningspunkter? I: Sundsfjord A, Walberg M, Jacobsen T, red. Resistensbestemmelse (Strategimøte 2004). Oslo: Nasjonalt folkehelseinstitutt, 2005: 6-8.
13. Amsden GW, Ballow CH, Bertino JS jr. et al. Pharmacokinetics and pharmacodynamics of antiinfective agents. I: Mandrell GL, Bennett JL, Dolin R, red. Principles and practice of infectious diseases. 6. utg. Baltimore: Churchill Livingstone, 2005: 271-81.
14. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for dosing of mice and men. Clin Infect Dis 1998; 26: 1-12.
15. Craig WA, Gudmundsson S. Postantibiotic effect. I: Lorian V, red. Antibiotics in laboratory medicine. 4. utg. Baltimore: Williams & Wilkins, 1996: 296-329.
16. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase-production in Enterobacteriaceae bacteremia: a systematic review and metaanalysis. J Antimicrob Chemother 2007; 60: 780-3.
17. Melander E, Burman LG, Cars O. Antibiotikaresistenta S. aureus ger ökad dödlighet och dyrare sjukvård. Läkartidningen 2007; 104: 3052-6.
18. Leegaard TM, Caugant DA, Frøholm LO et al. Apparent differences in antimicrobial susceptibility as a consequence of national guidelines. Clin Microbiol Infect 2000; 6: 290-3.
19. Steinbakk M. The EUCAST process of breakpoint setting in antibiotic susceptibility testing. I: NORM NORM-VET 2006. Usage of antimicrobials and occurrence of antimicrobial resistance in Norway. Tromsø/Oslo: NORM-VET, Universitetssykehuset Nord-Norge, 2007. www.antibiotikaresistens.no (22.9.2008).
20. Cantón R. Epidemiology and evolution of betalactamases. I: Baquero F, Nombela C, Cassell GH et al, red. Evolutionary biology of bacterial and fungal pathogens. Washington, D.C.: ASM Press, 2008: 249-70.
21. Onarheim H, Høvik T, Digranes A et al. Utbrudd av multiresistent Acinetobacter baumannii. Tidsskr Nor Lægeforen 2000; 120: 1028-33.
22. Vatopoulos A. High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece - a review of current evidence. Eurosurveillance 2008; 13, nr. 4. www.eurosurveillance. org/ViewArticle.aspx?ArticleId=8023 (22.9.2008).
23. Enright MC. The pneumococcus : population biology and virulence. I: Baquero F, Nombela C, Cassell GH et al, red. Evolutionary biology of bacterial and fungal pathogens. Washington, D.C.: ASM Press, 2008: 557-63.
24. Claverys J-P, Håvarstein LS. Cannibalism and fratricide: mechanisms and raison d'etre. Nat Rev Microbiol 2007; 5: 219-29.
25. Claverys J-P, Martin B, Håvarstein LS. Competence-induced fratricide in streptococci. Mol Microbiol 2007; 645: 1423-33.
26. Enright MC, Robinson DA, Randle G et al. The evolutionary history of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2002; 96: 7687-92.
27. Vila J. Epidemiology and evolution of quinolone resistance. I: Baquero F, Nombela C, Cassell GH et al, red. Evolutionary biology of bacterial and fungal pathogens. Washington, D.C.: ASM Press, 2008: 271-8.
28. Courvalin P. Evolution of glycopeptide resistance. I: Baquero F, Nombela C, Cassell GH et al, red. Evolutionary biology of bacterial and fungal pathogens. Washington, D.C.: ASM Press, 2008: 279-95.
29. Sørum M. Vancomycin resistant enterococci (VRE) in poultry after avaoparcin ban. I: NORM NORMVET 2006. Usage of antimicrobials and occurrence of antimicrobial resistance in Norway. Tromsø/ Oslo: NORM-VET, Universitetssykehuset Nord-Norge, 2006: 34. www.antibiotikaresistens.no (22.9.2008).
30. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999; 96: 1152-6.
31. Gossens H, Ferench M, Vander SR et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national study. Lancet 2005; 365: 579-85.
32. Enne VI, Livermore DM, Staphens P et al. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 2001; 357: 1325-8.
33. Brun JN. Import av resistente bakterier. Tidsskr Nor Lægeforen 2001; 121: 156.
34. Jenum PA, Høiby EA. Adoptivbarn fra Sør-Korea. MSIS-rapport 1984; 12: 28.
35. Kapperud G, Rørvik LM, Hasseltvedt V et al. Outbreak of Shigella sonnei infection traced to imported iceberg lettuce. J Clin Microbiol 1995; 33: 609-14.
36. Høiby EA, Kapperud G, Rørvik T. The tip of the iceberg. American Society for Microbiology News 1995; 61: 613.
37. Kristiansen B-E, Tveten Y. Resistensutvikling i viktige patogene bakterier. Tidsskr Nor Lægeforen 1995; 115: 2663-8.
38. Høiby EA, Sandven P, Lassen J et al. Antimikrobielle midler: grunnlag for fornuftig bruk. Oslo: Det norske radiumhospital, 1998.
39. NORM NORM-VET 2007. Usage of antimicrobials and occurrence of antimicrobial resistance in Norway. Tromsø/Oslo: NORM-VET, Universitetssykehuset Nord-Norge, 2008. www.antibiotikaresistens. no (22.9.2008).
40. The European Antimicrobial Resistance Surveillance System (EARSS).www.rivm.nl/earss/ (22.9.2008).
41. Meldingssystem for smittsomme sykdommer (MSIS). www.msis.no (22.9.2008).
42. Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Nature 1940: nr. 3713: 837.
43. Datta N, Kontomichalo P. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature1965; 208: 239-41.
44. STRAMA. Extended-spectrum beta-lactamases (ESBL) - ett kunnskapsunderlag om ESBL-resistens hos tarmbakterier. Solna: Samverkan mot antibiotikaresistens, 2007.
45. STRAMA. ESBL-resistens. Förslag till åtgärdsprogram - november 2007. Solna: Samverkan mot antibiotikaresistens, 2007.
46. Plan for å motvirke antibiotikaresistens. Oslo: Sosial- og helsedepartementet, 1999.
47. Cars O, Högberg LD, Murray M et al. Meeting the challenge of antibiotic resistance. BMJ 2008; 337: 727-8.